Drug profile · INN
calaspargase pegol-mknl
ASPARLAS
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
calaspargase pegol-mknl (ASPARLAS) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN calaspargase pegol-mknl
Brand ASPARLAS
Route INTRAVENOUS
Formulation INJECTABLE
Frequently asked questions
What is calaspargase pegol-mknl?
calaspargase pegol-mknl (ASPARLAS) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for calaspargase pegol-mknl?
ASPARLAS is a marketed brand name for calaspargase pegol-mknl. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of calaspargase pegol-mknl?
calaspargase pegol-mknl has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.